Perimetric Testing With Virtual Reality
A Pilot Study on the Repeatability of a Novel Perimetric Test Administered Via a Virtual Reality Headset.
1 other identifier
interventional
60
1 country
1
Brief Summary
Perimetry is an essential component in the diagnosis and monitoring of glaucoma. Since the advent of Standard Automated Perimetry (SAP), one of the clinical standards has been the Humphrey Field Analyzer (HFA, Carl Zeiss AG, Oberkochen, Germany). Visual field (VF) testing provided by the HFA is standard-of-care in glaucoma clinics and other ophthalmology and optometry practices. However, the HFA is a large device that does not allow for examination outside the clinic and can be uncomfortable for patients with limited mobility. This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients. The results of this study will potentially serve as pilot data for the design of a larger study that involves the full assessment of the VR headset and its VF test, based on various testing strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 3, 2024
CompletedFirst Submitted
Initial submission to the registry
August 2, 2024
CompletedFirst Posted
Study publicly available on registry
August 12, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedAugust 12, 2024
August 1, 2024
2 months
August 2, 2024
August 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Visual field perimetry light sensitivity
Localized differential light sensitivity threshold measured in decibels (dB)
1 day
Visual field perimetry foveal sensitivity
Foveal threshold in decibels (dB)
1 day
Visual field perimetry test duration
Test duration measured in minutes
1 day
Secondary Outcomes (1)
Optical Coherence Tomography (OCT)
1 day
Study Arms (2)
Healthy subjects
OTHER30 healthy subjects
Glaucoma subjects
OTHER30 glaucoma patients, 10 mild, 10 moderate, 10 severe
Interventions
This study aims to evaluate a novel head-mounted perimeter against the HFA as an alternative method of VF testing. This new perimeter uses a Virtual Reality (VR) headset and a gamified version of VF testing to assess the visual function of healthy eyes and patients.
Eligibility Criteria
You may not qualify if:
- Age range: 25-70 years
- For normal subjects:
- Patient is free of any current or prior ophthalmic pathologies that would potentially cause visual field defects: e.g. retina pathology, glaucoma, cataracts, keratoconus
- No ocular surgery other than cataract surgery within 6 months prior to the study visit
- For glaucoma subjects:
- Patient has a diagnosis of primary open-angle glaucoma
- Patient is free of any other current or prior ophthalmic pathologies that would potentially cause visual field defects.
- No other ocular surgery other than glaucoma or cataract surgery within 6 months prior to the study visit
- No IOP lower than 10 mm/Hg or higher than 30 mm/Hg
- Refractive Error:
- Sphere = up to -6.00 D to and up +3.00
- Cylinder = up to -3.00 is common
- No past refractive eye surgery
- No Multifocal or phakic (ICLs) IOL; no multifocal CLs
- One eligible eye
- +1 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Envision Health Technologies, Inc.lead
- Illinois College of Optometrycollaborator
Study Sites (1)
Illinois College of Optometry / Illinois Eye Institute
Chicago, Illinois, 60616, United States
Related Publications (4)
Montesano G, Bryan SR, Crabb DP, Fogagnolo P, Oddone F, McKendrick AM, Turpin A, Lanzetta P, Perdicchi A, Johnson CA, Garway-Heath DF, Brusini P, Rossetti LM. A Comparison between the Compass Fundus Perimeter and the Humphrey Field Analyzer. Ophthalmology. 2019 Feb;126(2):242-251. doi: 10.1016/j.ophtha.2018.08.010. Epub 2018 Aug 14.
PMID: 30114416BACKGROUNDMarin-Franch I, Turpin A, Artes PH, Chong LX, McKendrick AM, Alawa KA, Wall M. The Open Perimetry Initiative: A framework for cross-platform development for the new generation of portable perimeters. J Vis. 2022 Apr 6;22(5):1. doi: 10.1167/jov.22.5.1.
PMID: 35385053BACKGROUNDMarin-Franch I, Swanson WH. The visualFields package: a tool for analysis and visualization of visual fields. J Vis. 2013 Mar 14;13(4):10. doi: 10.1167/13.4.10.
PMID: 23492926BACKGROUNDBradley C, Ahmed IIK, Samuelson TW, Chaglasian M, Barnebey H, Radcliffe N, Bacharach J. Validation of a Wearable Virtual Reality Perimeter for Glaucoma Staging, The NOVA Trial: Novel Virtual Reality Field Assessment. Transl Vis Sci Technol. 2024 Mar 1;13(3):10. doi: 10.1167/tvst.13.3.10.
PMID: 38488433BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Chaglasian, OD
Illinois College of Optometry
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- FACTORIAL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 2, 2024
First Posted
August 12, 2024
Study Start
July 3, 2024
Primary Completion
September 1, 2024
Study Completion
October 1, 2024
Last Updated
August 12, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- The data will submitted for publication in a medical journal, within 3-6 months of completion of the data analysis of the monitored and locked database.
- Access Criteria
- The trial results will be published in an open-access medical journal.
De-identified data and data analysis will be shared for communication of results and learning conclusions.